Cerebral toxoplasmosis treated with clindamycin alone in an HIV-positive patient allergic to sulfonamides [3]

International Journal of Infectious Diseases

Volumn 9, Issue 1, 2005, Pages 64-66

  Yapar, Nur ^a   Erdenizmenli, Mine ^a   Oǧuz, Vildan Avkan ^a   Çakir, Nedim ^a   Yüce, Ayşe ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; SULFONAMIDE;

DRUG HYPERSENSITIVITY; DRUG SAFETY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; NEUROLOGIC EXAMINATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; SIDE EFFECT; TOXOPLASMOSIS; VIRUS INFECTION;

ADULT; CLINDAMYCIN; COCCIDIOSTATS; FEMALE; HIV INFECTIONS; HUMANS; TOXOPLASMOSIS, CEREBRAL;

EID: 10444275515     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2004.05.004     Document Type: Letter

References (12)

1. L.F.C. Giordano, E.P. Lasmar, E.R.F. Tavora, and M.F. Lasmar Toxoplasmosis transmitted via kidney allograft: Case report and review Transplant Proc 34 2002 498 499
2. J.G. Montoya, and J.S. Remington Toxoplasma gondii G.L. Mandell J.E. Bennett R. Dolin Principles and practice of infectious diseases 5th ed. 2000 Churchill Livingstone New York 2858 2888
3. G. Gatti, M. Malena, R. Casazza, M. Borin, M. Bassetti, and M. Cruciani Penetration of clindamycin and its metabolite N-demethylclindamycin into cerebrospinal fluid following intravenous infusion of clindamycin phosphate in patients with AIDS Antimicrob Agents Chemother 42 1998 3014 3017
4. F.J. San-Andrés, R. Rubio, and J. Castilla Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus Clin Infect Dis 36 2003 1177 1185
5. I.V.D. Weller, and I.G. Williams ABC of AIDS. Treatment of infections BMJ 322 2001 1350 1354
6. J.P. Alappat, C.F. Mathew, J. Jayakumar, I.C.L. Suresh, and S. Kumar A case of cerebral toxoplasmosis Neurology India 48 2000 185 186
7. P.B. Vastava, S. Pradhan, S. Jha, K.N. Prasad, S. Kumar, and R.K. Gupta MRI features of toxoplasma encephalitis in the immunocompetent host: a report of two cases Neuroradiology 44 2002 834 838
8. A. Mamidi, J. DeSimone, and R. Pomerantz Central nervous system infections in individuals with HIV infection J Neurovirol 8 2002 158 167
9. E. Roemer, I.W. Blau, and N. Basara Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: Successful treatment strategies during a 5-year single center experience Clin Infect Dis 32 2001 E1 E8
10. B. Danneman, A. McCutchan, and D. Israelski Treatment of toxoplasmic encephalitis in patients with AIDS Ann Intern Med 116 1992 33 43
11. T. Nikolic, O. Djurkovic-Djurkovic, B. Bobic, A. Nikolic, and D. Babic Treatment protocol determines the efficacy of clindamycin in acute murine toxoplasmosis Int J Antimicrob Agents 11 1999 145 149
12. E.R. Pfefferkorn, R.F. Nothnagel, and S.E. Borotz Parasiticidal effect of clindamycin on Toxoplasma gondii grown in cultured cells and selection of a drug resistant mutant Antimicrob Agents Chemother 36 1992 1091 1096